search
Back to results

Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Children Using Transthoracic Echocardiography (PREDIPEN)

Primary Purpose

Fluid Therapy, Hemodynamics, Hypovolemia

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Echocardiographic assessment
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Fluid Therapy focused on measuring children, critically ill, fluid therapy, fluid responsiveness, hemodynamics, hypovolemia, shock, echocardiography

Eligibility Criteria

undefined - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria :

  • Patient < 18 years (child and neonate)
  • Sedated and mechanically ventilated under controlled-mode ventilation
  • In whom fluid administration was planned by the attending physicians

Exclusion Criteria :

  • High-frequency oscillatory ventilation
  • Cardiac arrhythmia
  • Congenital heart defect

Sites / Locations

  • Bicetre HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Echocardiographic assessment

Arm Description

At baseline before standardized volume expansion, a first set of echocardiographic measurements will be performed. Then, we will perform 15-second end-expiratory and end-inspiratory occlusions. Occlusions will be separated by 1 minute to allow the cardiac index to return to its baseline value. A last set of measurements will be performed after fluid administration. Ventilatory settings and other treatments will remain unchanged during the study period.

Outcomes

Primary Outcome Measures

Cardiac index measured by transthoracic echocardiography
After fluid administration, patients who present an increase of cardiac index measured by transthoracic echocardiography greater than or equal to 15% of baseline measurement will be considered responders .

Secondary Outcome Measures

End-tidal carbon dioxide levels
ETCO2 measurements using sidestream microstream technology before and after fluid administration will be compared to cardiac index measured by transthoracic echocardiography, ETCO2 increment of 5% is expected in responders patients.

Full Information

First Posted
June 21, 2021
Last Updated
December 6, 2021
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT05054452
Brief Title
Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Children Using Transthoracic Echocardiography
Acronym
PREDIPEN
Official Title
Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Children and Neonates Using Transthoracic Echocardiography
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Unknown status
Study Start Date
June 25, 2021 (Actual)
Primary Completion Date
August 30, 2023 (Anticipated)
Study Completion Date
August 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Initial fluid resuscitation remains the first treatment step for most children experiencing circulatory failure and/or systemic hypotension. Only one-half of these patients respond to fluid administration by a significant increase in cardiac output. A positive fluid balance is a poor prognostic factor that increases mortality. There are few markers validated in children to assess volume reactivity by dynamic ultrasound parameters mainly based on heart-lung interaction. In this work, the investigators propose to investigate whether dynamic parameters validated in adults, such as the superior vena caval collapsibility and the variability of cardiac output during an end-expiratory and end-inspiratory occlusion, are also reliable indicators of volume responsiveness in sedated children under controlled-mode ventilation.
Detailed Description
After standardized volume expansion, patients who present an increase of cardiac index measured by transthoracic echocardiography greater than or equal to 15% of baseline measurement will be considered responders . A previous similar study using respiratory variations in aortic blood flow to predict fluid responsiveness in ventilated children reported a ROC curve area 0.85, while the prevalence rate of circulatory failure was 50%. Given these assumptions, a sample size of 38 subjects per group (Responders / No responders) was estimated to provide a AUC equivalent. A total of 76 subjects should be included.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fluid Therapy, Hemodynamics, Hypovolemia, Shock
Keywords
children, critically ill, fluid therapy, fluid responsiveness, hemodynamics, hypovolemia, shock, echocardiography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
76 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Echocardiographic assessment
Arm Type
Experimental
Arm Description
At baseline before standardized volume expansion, a first set of echocardiographic measurements will be performed. Then, we will perform 15-second end-expiratory and end-inspiratory occlusions. Occlusions will be separated by 1 minute to allow the cardiac index to return to its baseline value. A last set of measurements will be performed after fluid administration. Ventilatory settings and other treatments will remain unchanged during the study period.
Intervention Type
Device
Intervention Name(s)
Echocardiographic assessment
Intervention Description
At baseline before standardized volume expansion, a first set of echocardiographic measurements will be performed. Then, we will perform 15-second end-expiratory and end-inspiratory occlusions. Occlusions will be separated by 1 minute to allow the cardiac index to return to its baseline value. A last set of measurements will be performed after fluid administration. Ventilatory settings and other treatments will remain unchanged during the study period.
Primary Outcome Measure Information:
Title
Cardiac index measured by transthoracic echocardiography
Description
After fluid administration, patients who present an increase of cardiac index measured by transthoracic echocardiography greater than or equal to 15% of baseline measurement will be considered responders .
Time Frame
Through the end of the hospitalisation, a maximum of 2 months
Secondary Outcome Measure Information:
Title
End-tidal carbon dioxide levels
Description
ETCO2 measurements using sidestream microstream technology before and after fluid administration will be compared to cardiac index measured by transthoracic echocardiography, ETCO2 increment of 5% is expected in responders patients.
Time Frame
Through the end of the hospitalisation, a maximum of 2 months

10. Eligibility

Sex
All
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria : Patient < 18 years (child and neonate) Sedated and mechanically ventilated under controlled-mode ventilation In whom fluid administration was planned by the attending physicians Exclusion Criteria : High-frequency oscillatory ventilation Cardiac arrhythmia Congenital heart defect
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Simon Barreault, Doctor
Phone
+33145213205
Email
simon.barreault@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Simon Barreault, Doctor
Organizational Affiliation
Bicetre Hospital (AP-HP)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bicetre Hospital
City
Le Kremlin-Bicêtre
ZIP/Postal Code
94270
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Simon BARREAULT, Doctor
Phone
+33 1 45 21 32 05
Email
simon.barreault@aphp.fr

12. IPD Sharing Statement

Citations:
PubMed Identifier
18259726
Citation
Durand P, Chevret L, Essouri S, Haas V, Devictor D. Respiratory variations in aortic blood flow predict fluid responsiveness in ventilated children. Intensive Care Med. 2008 May;34(5):888-94. doi: 10.1007/s00134-008-1021-z. Epub 2008 Feb 8.
Results Reference
background

Learn more about this trial

Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Children Using Transthoracic Echocardiography

We'll reach out to this number within 24 hrs